{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:07Z","timestamp":1772166667030,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>One of the emotional problems in patients experiencing cancer is demoralization syndrome. Concerning the importance of demoralization in patients with cancer, having a valid and reliable scale for assessing this problem is crucial. A revised version of Demoralization Scale (DS-II) was designed in 2016. It was necessary to determine its validity and reliability in populations with different cultures. This study aimed to determine the psychometric properties of the Persian version of DS-II (PDS-II) in Iranian patients with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study population comprised 170 Iranian patients with cancer in Ardabil, Iran. The inclusion criteria were: age 18 or more, ability to understand and speak Persian, willingness to consent to participate in the study, having healthy cognitive function, and having an awareness of cancer. To determine the psychometric properties of PDS-II, the content, convergent, construct, and discriminant validity, besides internal consistency, were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Regarding the high correlation of PDS-II with General Anxiety Disorder, Patient Health Questionnaire, Beck Hopelessness Scale, and Hospital Anxiety and Depression Scale, the convergent validity of the PDS-II was confirmed. Confirmatory factor analyses confirmed both the original 2-factor and one-factor models of PDS-II. Internal discriminant validity of the PDS-II was not confirmed because the Average Variance Extracted from two dimensions of PDS-II (AVE\u2009=\u20090.31 and 0.37) was less than the square correlation between these two dimensions (r\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.79). Cronbach \u03b1 and coefficient was 0.88 for the PDS-II.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PDS-II is a valid and reliable scale for measuring demoralization among Iranian people with cancer. However, the discriminant validity of the PDS-II was not supported.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40359-023-01507-6","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T03:03:14Z","timestamp":1704164594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Determining psychometric properties of the Persian version of demoralization scale-II in patients with cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Elaheh","family":"Taghilou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Heidarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Molaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi Ajri","family":"Khameslou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"4","key":"1507_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Intern J Cancer. 2021;149(4):778\u201389.","journal-title":"Intern J Cancer"},{"key":"1507_CR2","unstructured":"Cancer IAfRo. World Health Organization Global Cancer Observatory. 2021. https:\/\/gco.iarc.fr. Accessed March, 2021."},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02760-4","volume":"20","author":"M Iddrisu","year":"2020","unstructured":"Iddrisu M, Aziato L, Dedey F. Psychological and physical effects of Breast cancer diagnosis and treatment on young Ghanaian women: a qualitative study. BMC Psychiatry. 2020;20:1\u20139.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"1507_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer. Nat Med. 2021;27(1):34\u201344.","journal-title":"Nat Med"},{"key":"1507_CR5","doi-asserted-by":"crossref","unstructured":"Sawyer AT, Harris SL, Koenig HG. Illness perception and high readmission health outcomes. Health Psychol Open. 2019;6(1).","DOI":"10.1177\/2055102919844504"},{"key":"1507_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fpsyg.2021.585534","volume":"12","author":"AY Naser","year":"2021","unstructured":"Naser AY, Hameed AN, Mustafa N, Alwafi H, Dahmash EZ, Alyami HS, et al. Depression and anxiety in patients with cancer: a cross-sectional study. Front Psychol. 2021;12:1067.","journal-title":"Front Psychol"},{"issue":"4","key":"1507_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4314\/ejhs.v32i4.6","volume":"32","author":"A Jadidi","year":"2022","unstructured":"Jadidi A, Ameri F. Social support and meaning of life in women with Breast cancer. Ethiop J Health Sci. 2022;32(4):709\u201314.","journal-title":"Ethiop J Health Sci"},{"issue":"3","key":"1507_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jpainsymman.2014.07.008","volume":"49","author":"S Robinson","year":"2015","unstructured":"Robinson S, Kissane DW, Brooker J, Burney S. A systematic review of the demoralization syndrome in individuals with Progressive Disease and cancer: a decade of research. J Pain Symptom Manage. 2015;49(3):595\u2013610.","journal-title":"J Pain Symptom Manage"},{"key":"1507_CR9","doi-asserted-by":"crossref","unstructured":"Grassi L, Nanni MG. Demoralization syndrome: new insights in psychosocial cancer care. Wiley Online Libr. 2016;2130\u20133.","DOI":"10.1002\/cncr.30022"},{"issue":"17","key":"1507_CR10","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1002\/cncr.30749","volume":"123","author":"S Vehling","year":"2017","unstructured":"Vehling S, Kissane DW, Lo C, Glaesmer H, Hartung TJ, Rodin G, et al. The association of demoralization with mental disorders and suicidal ideation in patients with cancer. Cancer. 2017;123(17):3394\u2013401.","journal-title":"Cancer"},{"issue":"5","key":"1507_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0010-440X(93)90016-W","volume":"34","author":"JM De Figueiredo","year":"1993","unstructured":"De Figueiredo JM. Depression and demoralization: phenomenologic differences and research perspectives. Compr Psychiatry. 1993;34(5):308\u201311.","journal-title":"Compr Psychiatry"},{"issue":"4","key":"1507_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2307\/3528690","volume":"34","author":"DW Kissane","year":"2004","unstructured":"Kissane DW. The contribution of demoralization to end-of-life decision-making. Hastings Cent Rep. 2004;34(4):21\u201331.","journal-title":"Hastings Cent Rep"},{"key":"1507_CR13","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/cncr.30012","volume":"122","author":"S Robinson","year":"2016","unstructured":"Robinson S, Kissane DW, Brooker J, Hempton C, Michael N, Fischer J, et al. Refinement and revalidation of the demoralization scale: the DS-II external validity. Cancer. 2016;122:2260\u20137.","journal-title":"Cancer"},{"issue":"3","key":"1507_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jpainsymman.2018.11.016","volume":"57","author":"A Belar","year":"2019","unstructured":"Belar A, Arantzamendi M, Rodr\u00edguez-N\u00fa\u00f1ez A, Santesteban Y, Martinez M, L\u00f3pez-Saca M, et al. Multicenter study of the psychometric properties of the new demoralization scale (DS-II) in spanish-speaking advanced cancer patients. J Pain Symptom Manage. 2019;57(3):627\u201334.","journal-title":"J Pain Symptom Manage"},{"key":"1507_CR15","doi-asserted-by":"crossref","unstructured":"Koranyi S, Hinz A, Hufeld JM, Hartung TJ, Quintero Garzon L, Fendel U et al. Psychometric evaluation of the German version of the demoralization Scale-II and the Association between Demoralization, Sociodemographic, Disease-and treatment-related factors in patients with Cancer. Front Psychol. 2021;5489.","DOI":"10.3389\/fpsyg.2021.789793"},{"issue":"14","key":"1507_CR16","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/cncr.30015","volume":"122","author":"S Robinson","year":"2016","unstructured":"Robinson S, Kissane DW, Brooker J, Michael N, Fischer J, Franco M, et al. Refinement and revalidation of the demoralization scale: the DS-II internal validity. Cancer. 2016;122(14):2251\u20139.","journal-title":"Cancer"},{"issue":"6","key":"1507_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/NCC.0000000000000537","volume":"41","author":"M Heidarzadeh","year":"2018","unstructured":"Heidarzadeh M, Rassouli M, Brant JM, Mohammadi-Shahbolaghi F, Alavi-Majd H. Dimensions of posttraumatic growth in patients with Cancer: a mixed method study. Cancer Nurs. 2018;41(6):441\u20139.","journal-title":"Cancer Nurs"},{"key":"1507_CR18","doi-asserted-by":"crossref","unstructured":"Schumacker RE, Lomax RG. A beginner\u2019s guide to structural equation modeling. Psychol Press; 2004.","DOI":"10.4324\/9781410610904"},{"key":"1507_CR19","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure: Slack Inc Thorofare, NJ 2002. p.509\u2009\u2013\u200915.","DOI":"10.3928\/0048-5713-20020901-06"},{"issue":"2","key":"1507_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.32598\/ijpcp.27.2.3375.1","volume":"27","author":"H Farrahi","year":"2021","unstructured":"Farrahi H, Gharraee B, Oghabian MA, Zare R, Pirmoradi MR, Najibi SM, et al. Psychometric properties of the Persian Version of Patient Health Questionnaire-9. Iran J Psychiatr Clin Psychol. 2021;27(2):248\u201363.","journal-title":"Iran J Psychiatr Clin Psychol"},{"issue":"6","key":"1507_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1037\/h0037562","volume":"42","author":"AT Beck","year":"1974","unstructured":"Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clini Psychol. 1974;42(6):861.","journal-title":"J Consult Clini Psychol"},{"key":"1507_CR22","volume-title":"Interview and psychological tests","author":"H Kaviyani","year":"2021","unstructured":"Kaviyani H, Mousavi A. Interview and psychological tests. 4rd ed. Tehran: Mehr Kavian; 2021. [Persian].","edition":"4"},{"issue":"10","key":"1507_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1507_CR24","first-page":"41","volume":"9","author":"M Nainian","year":"2011","unstructured":"Nainian M, Shairi M, Sharifi M, Hadian M. Investigating the reliability and validity of the short limit of generalized inhibition scale (GAD-7). Clin Psychol Personal. 2011;9(1):41\u201350. [Persian].","journal-title":"Clin Psychol Personal"},{"issue":"6","key":"1507_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"1507_CR26","first-page":"379","volume":"67","author":"H Kaviani","year":"2009","unstructured":"Kaviani H, Seyfourian H, Sharifi V, Ebrahimkhani N. Reliability and validity of anxiety and Depression Hospital scales (HADS): Iranian patients with anxiety and depression disorders. Tehran Univ M\u00e9d J. 2009;67:379\u201385.","journal-title":"Tehran Univ M\u00e9d J"},{"issue":"2","key":"1507_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94\u2013104.","journal-title":"Value Health"},{"issue":"4","key":"1507_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/nur.20199","volume":"30","author":"DF Polit","year":"2007","unstructured":"Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459\u201367.","journal-title":"Res Nurs Health"},{"key":"1507_CR29","first-page":"731","volume":"38","author":"SR Carter","year":"2016","unstructured":"Carter SR. Using confirmatory factor analysis to manage discriminant validity issues in social pharmacy research. Int J Clin Pharm. 2016;38:731\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1507_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/002224378101800104","volume":"18","author":"C Fornell","year":"1981","unstructured":"Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18(1):39\u201350.","journal-title":"J Mark Res"},{"issue":"3","key":"1507_CR31","first-page":"52","volume":"1","author":"MI Khairi","year":"2021","unstructured":"Khairi MI, Susanti D, Firman S. Study on Structural Equation Modeling for Analyzing Data. Int Ethno-Sci Educ Res J. 2021;1(3):52\u201360.","journal-title":"Int Ethno-Sci Educ Res J"},{"key":"1507_CR32","doi-asserted-by":"crossref","unstructured":"Mehnert A, Vehling S, Hocker A, Lehmann C, Koch U. Demoralization and Depression in Patients With Advanced Cancer: Validation of the German Version of the Demoralization Scale. J Pain Symptom Manage. 2011; 42(5):768-76.","DOI":"10.1016\/j.jpainsymman.2011.02.013"}],"container-title":["BMC Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-023-01507-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40359-023-01507-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-023-01507-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T06:12:28Z","timestamp":1721283148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychology.biomedcentral.com\/articles\/10.1186\/s40359-023-01507-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1186\/s40359-023-01507-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3139070\/v1","asserted-by":"object"}]},"ISSN":["2050-7283"],"issn-type":[{"value":"2050-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"4 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Ardabil University of Medical Sciences (Approval no. IR.ARUMS.REC.1401.101), therefore, it guarantees that the standards set by the Declaration of Helsinki are met. The objectives and methods of the study, the optionality of participating in the study and guaranteed anonymity were explained to the participants, and then informed consent was obtained from them. For illiterate patients, the informed consent form was read to them, and after verbally declaring their consent to participate in the study, other steps were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}